Epigenomics AG (LON:0QXH)
London · Delayed Price · Currency is GBP · Price in EUR 0.8820
-0.0080 (-0.90%)
At close: Nov 14, 2025
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of 689.1 thousand as of December 30, 2025. Its market cap has decreased by -35.57% in one year.
Market Cap
689.10K
Enterprise Value
9.96M
Revenue
3.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 40.84M to 689.10K, a decrease of -98.31%. That is a compound annual growth rate of -30.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 688.25K | -15.31% |
| Dec 30, 2024 | 812.70K | -40.99% |
| Dec 29, 2023 | 1.38M | -77.01% |
| Dec 30, 2022 | 5.99M | -12.75% |
| Dec 30, 2021 | 6.87M | -60.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| HSBC Holdings | 201.54B |
| Shell | 154.45B |
| Unilever | 107.12B |
| Rio Tinto Group | 102.20B |
| Rolls-Royce Holdings | 96.22B |
| British American Tobacco p.l.c. | 91.59B |
| GSK plc | 72.45B |